Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.

Saved in:
Bibliographic Details
Title: Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.
Authors: Melo-Carrillo A; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Anesthesia, Harvard Medical School, Boston, MA, USA., Strassman AM; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Anesthesia, Harvard Medical School, Boston, MA, USA., Schain AJ; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Anesthesia, Harvard Medical School, Boston, MA, USA., Adams AM; Allergan, an AbbVie Company, Irvine, CA, USA., Brin MF; Allergan, an AbbVie Company, Irvine, CA, USA.; University of California, Irvine, Irvine, CA, USA., Burstein R; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Anesthesia, Harvard Medical School, Boston, MA, USA.
Source: Cephalalgia : an international journal of headache [Cephalalgia] 2021 Jan; Vol. 41 (1), pp. 17-32. Date of Electronic Publication: 2020 Nov 17.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1468-2982
DOI:10.1177/0333102420970507